Skip to content

Translation of Eye Movement Reading Training to Clinical Practice

Translation of Eye Movement Reading Training to Clinical Practice

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01853930
Enrollment
33
Registered
2013-05-15
Start date
2014-01-01
Completion date
2017-06-30
Last updated
2019-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular Disease

Keywords

reading rehabilitation, macular degeneration, eccentric viewing

Brief summary

Age-related macular degeneration (AMD) is the most common visual impairment in persons over 50 years of age. It has been estimated that 1 in 3 individuals over 75 years of age and 1 in 30 individuals over 52 years of age are affected by AMD. The deficits in visual function as a result of this disease affecting the central retina are debilitating, as individuals lose their ability to carry out many of their daily activities that require resolving fine spatial details. The investigator's previous studies have shown that training with oculomotor control exercises significantly increases reading speeds in patients with AMD. In the proposed study, the investigators will examine whether these training exercises are effective when practiced at home. In Phase 1, the investigators will develop a standardized user-friendly, Web-based platform that will allow patients to easily self-administer training exercises. The software platform will be designed to automatically choose the appropriate exercises based on a patient's previous performance, run the training exercise, and collect performance data into a universal patient data file. In Phase 2, the platform will be tested in two settings: in standard clinical rehabilitation practice and in the patient's home. Reading outcomes in the two settings will be compared. The investigators will recruit 60 patients per year for each of the three years for Phase 2 of the study. Half of these patients will be assigned to the Clinic Training Group, while the other half will be assigned to At-home Training Group. For all patients, three assessments will be taken: at baseline, after 1 month, and after 2 months of training. The investigators will compare reading outcomes to assess the roles of feedback versus the role of frequent available practice. Because of the extensive cost and clinical resources required for vision rehabilitation, it is critical to determine whether the training program can be made less expensive, but as effective, when it is self-trained. If the investigators demonstrate the utility of at-home practice, clinical facilities and therapists' time can be made available for those activities requiring face-to-face contact

Detailed description

In the proposed study, the investigators will examine whether these training exercises are effective when practiced at home. There are two specific aims in this project: Aim #1 (Year 1): to develop a web-based meta program that will administer the training exercises. For convenience, in this proposal, the investigators will refer to this platform as PAECT (Platform for Administering Eye movement Control Training). The PAECT meta program will incorporate all of the exercises that the investigators have developed and validated over the course of our previous Merit Review grants (Seiple, Szlyk et al., 2005, 2011). The PAECT platform will be designed to allow patients to easily run the training exercises in their homes and to practice at their convenience. The PAECT will employ an executive component that will keep track of the exercises that are practiced and record performance. Each time a subject opens the platform, it will choose the exercise for that subject based upon previous training and performance. The development of the software and the design of the hardware interface for administering the system will take place during the first year of the project. This will be done through a series of software/hardware iterations based upon feedback derived from direct patient testing of the system. The investigators will recruit ten patients with AMD to test and comment on the system during this phase of the project. Aim #2 (Years 2-4). To compare the effects of PAECT training on reading outcomes in two training situations: (1). training done in the clinic with feedback on performance provided by a trained low-vision therapist, and (2) training done at-home with expanded opportunity for practicing the exercises, but with no therapist feedback. Patients will be assigned to one of two groups: Patients in Group 1 (Clinical) will undergo weekly two-hour training sessions for three months using the software/hardware system. This training will be conducted in the low-vision clinic using the PAECT, with feedback on performance provided by a trained low-vision therapist. Patients in Group 2 (At-home) will practice all of the exercises at home using the PAECT system over a three-month period. The subjects will be encouraged to use the system as often as possible, but no less than two hours per week. Sixty patients (30 in the clinical setting and 30 at home) will be tested for each of three years.

Interventions

BEHAVIORALPlatform for Administering Eye-movement Control Training

The Platform for Administering Eye-movement Control Training (PAECT) meta program will incorporate all of the exercises that the investigators have developed and validated over the course of our previous Merit Review grants (Seiple, Szlyk et al., 2005, 2011). The PAECT platform will be designed to allow patients to easily run the training exercises in their homes and to practice at their convenience. The PAECT will employ an executive component that will keep track of the exercises that are practiced and record performance. Each time a subject opens the platform, it will choose the exercise for that subject based upon previous training and performance.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with a diagnosis of retinal disease affecting the central visual field (e.g., non-exudative dry AMD) * with a central scotoma * and with visual acuity of less than or equal to 20/70 and greater than or equal to 20/400 (in the test eye), will be included in the study. * The presence of a central scotoma and eccentric viewing will be confirmed using an OPKO OCT/SLO microperimetry. * The investigator's intent is to include subjects based upon the patient's functional characteristics (e.g., eccentric viewing).

Exclusion criteria

* Patients with other major ophthalmologic or neurologic disease * choroidal neovascularization (wet AMD) * moderate to severe media opacities * and cognitive impairment will be excluded. * Patients' disease status will be monitored throughout the study.

Design outcomes

Primary

MeasureTime frameDescription
Change in Reading Performance and Accuracy Using MNREAD.Participants will be assessed at baseline, 1 month and 2 months but change between baseline and final (2 months) will be reportedParticipants will be trained to use eccentric viewing for reading. They will then be assessed on the following outcome measures; reading, speed and accuracy using the MNRead test, binocular visual acuity and contrast sensitivity.

Countries

United States

Participant flow

Recruitment details

98 patients were screened for eligibility between January 2014 and June 2017 at the Jesse Brown VA Medical Center in Chicago, Illinois.

Pre-assignment details

33 patients were assigned to either the laboratory training group or the home-based training group. 14 were assigned to the focus group during the developmental phase (year 1) of the web-based meta program and are not included in the analysis of outcome measures. 26 did not meet the inclusion criteria and 25 declined to participate.

Participants by arm

ArmCount
Laboratory Training
Patients will be trained in the laboratory by a rehabilitation therapist The Platform for Administering Eye movement Control Training (PAECT) meta program will incorporate all of the exercises that the investigators have developed and validated over the course of our previous Merit Review grants (Seiple, Szlyk et al., 2005, 2011). The PAECT platform will be designed to allow future patients to easily run the training exercises in their homes and to practice at their convenience. The PAECT will employ an executive component that will keep track of the exercises that are practiced and record performance. Each time a subject opens the platform, it will choose the exercise for that subject based upon previous training and performance.
25
Home-based Training
Patients will self instruct using the computer-based training with remote intervention by a therapist as needed The Platform for Administering Eye movement Control Training (PAECT) meta program will incorporate all of the exercises that the investigators have developed and validated over the course of our previous Merit Review grants (Seiple, Szlyk et al., 2005, 2011). The PAECT platform will be designed to allow future patients to easily run the training exercises in their homes and to practice at their convenience. The PAECT will employ an executive component that will keep track of the exercises that are practiced and record performance. Each time a subject opens the platform, it will choose the exercise for that subject based upon previous training and performance.
8
Total33

Baseline characteristics

CharacteristicTotalHome-based TrainingLaboratory Training
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
20 Participants6 Participants14 Participants
Age, Categorical
Between 18 and 65 years
13 Participants2 Participants11 Participants
Age, Continuous68.1 years
STANDARD_DEVIATION 22.1
75.9 years
STANDARD_DEVIATION 11.9
65.6 years
STANDARD_DEVIATION 24.1
Contrast1.03 logCS
STANDARD_DEVIATION 0.42
1.08 logCS
STANDARD_DEVIATION 0.41
1.01 logCS
STANDARD_DEVIATION 0.43
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants0 Participants2 Participants
Race (NIH/OMB)
Black or African American
5 Participants1 Participants4 Participants
Race (NIH/OMB)
More than one race
2 Participants0 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
24 Participants7 Participants17 Participants
Reading Performance and Accuracy55.7 Words Per Minute (WPM)
STANDARD_DEVIATION 40.2
40.9 Words Per Minute (WPM)
STANDARD_DEVIATION 35.6
60.4 Words Per Minute (WPM)
STANDARD_DEVIATION 41.1
Region of Enrollment
United States
33 Participants8 Participants25 Participants
Sex: Female, Male
Female
21 Participants5 Participants16 Participants
Sex: Female, Male
Male
12 Participants3 Participants9 Participants
Visual Acuity0.96 logMAR
STANDARD_DEVIATION 0.24
0.98 logMAR
STANDARD_DEVIATION 0.27
0.95 logMAR
STANDARD_DEVIATION 0.23

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 8
other
Total, other adverse events
0 / 250 / 8
serious
Total, serious adverse events
0 / 250 / 8

Outcome results

Primary

Change in Reading Performance and Accuracy Using MNREAD.

Participants will be trained to use eccentric viewing for reading. They will then be assessed on the following outcome measures; reading, speed and accuracy using the MNRead test, binocular visual acuity and contrast sensitivity.

Time frame: Participants will be assessed at baseline, 1 month and 2 months but change between baseline and final (2 months) will be reported

Population: All 33 participants who received and completed training on the PAECT platform for eight weeks (in the laboratory or at-home) were included in the analysis.

ArmMeasureValue (MEAN)Dispersion
Laboratory TrainingChange in Reading Performance and Accuracy Using MNREAD.22.59 Words Per Minuted (WPM)Standard Deviation 26.51
Home-based TrainingChange in Reading Performance and Accuracy Using MNREAD.24.68 Words Per Minuted (WPM)Standard Deviation 17.76
p-value: 0.876t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026